The Asia Pacific PACS and RIS market is estimated to grow at a CAGR of 8.1% from 2019 - 2027. The market of PACS and RIS in the Asia Pacific region is majorly contributed by the Japan. Factors leading to the growth of the PACS and RIS Market in Asia Pacific are, rising incidence as well as mortality rates of cancer, awareness about early diagnosis. The market of PACS and RIS is expected to reach up to US$ 1,223.18 Mn by the end of 2027. The top 10 industry players operating in the market of PACS and RIS across the globe includes McKesson Corporation, General Electric, Fujifilm Holdings Corporation, Koninklijke Philips N.V., Siemens AG, Cerner Corporation, IBM, Novarad, Agfa-Gevaert Group, and INFINITT Healthcare Co., Ltd.

1. Introduction 

2. Asia Pacific PACS and RIS Market – Key Takeaways 

3. Asia Pacific PACS and RIS Market – Market Landscape.29

4. Asia Pacific PACS and RIS Market - Key Market Dynamics 

5. PACS and RIS Market – Asia Pacific Analysis 

6. Asia Pacific PACS and RIS Market Analysis – By Product